{
  "personality": null,
  "timestamp": "2025-09-07T04:30:54.251188",
  "category": "Health",
  "news_summary": "Advancements in health reveal promising potential of a common supplement to counteract sucralose damage and the emergence of gene-edited animals through CRISPR technology.",
  "news_summary_fr": "Les progrès dans le domaine de la santé révèlent le potentiel prometteur d'un supplément commun pour contrer les dommages causés par le sucralose et l'émergence d'animaux génétiquement modifiés grâce à la technologie CRISPR.",
  "news_summary_es": "Los avances en salud revelan el prometedor potencial de un suplemento común para contrarrestar los daños de la sucralosa y la aparición de animales editados genéticamente mediante la tecnología CRISPR.",
  "articles": [
    {
      "title": "A common supplement could reverse the hidden harm of sucralose",
      "summary": "Sucralose, the sugar substitute in many diet products, may weaken cancer immunotherapy by altering gut bacteria and reducing arginine levels needed for immune cells. But supplementation with arginine or citrulline could counteract this effect, pointing to new clinical trial possibilities.",
      "content": "Sucralose is a popular sugar substitute for people who are cutting calories or managing blood sugar levels, but new research by the University of Pittsburgh and UPMC Hillman Cancer Center suggests that the artificial sweetener may not be the best choice for patients undergoing cancer immunotherapy.\n\nPublishing recently in Cancer Discovery, a publication of the American Association for Cancer Research, the study found that patients with melanoma and non-small cell lung cancer who consumed high levels of sucralose had worse response to immunotherapy and poorer survival than those with diets low in the artificial sweetener.\n\nStrikingly, supplements that boosted levels of the amino acid arginine mitigated the negative effects of sucralose on immunotherapy in mice, an approach that could now be tested in clinical trials.\n\n\"It's easy to say, 'Stop drinking diet soda,' but when patients are being treated for cancer, they are already dealing with enough, so asking them to drastically alter their diet may not be realistic,\" said lead author Abby Overacre, Ph.D., assistant professor in the Department of Immunology at Pitt and UPMC Hillman. \"We need to meet patients where they are. That's why it's so exciting that arginine supplementation could be a simple approach to counteract the negative effects of sucralose on immunotherapy.\"\n\nSenior author Diwakar Davar, M.D., associate professor of medicine at Pitt and a medical oncologist and hematologist at UPMC Hillman, collaborating with Overacre and their team, used mouse models to show that the negative impacts of sucralose are driven by disruption to gut bacteria.\n\nSucralose shifted the composition of the mouse gut microbiome, increasing bacterial species that degrade arginine, which reduced levels of this amino acid in the blood, tumor fluid and stool.\n\nImmune checkpoint inhibitor immunotherapies such as anti-PD1 work by ramping up T cell activity so that they can more effectively kill cancer cells. Arginine is essential for T cell function, especially in cancer.\n\n\"When arginine levels were depleted due to sucralose-driven shifts in the microbiome, T cells couldn't function properly,\" said Overacre. \"As a result, immunotherapy wasn't as effective in mice that were fed sucralose.\"\n\nIn mouse models of adenocarcinoma and melanoma, adding sucralose to the diet inhibited anti-PD1 therapy, leading to larger tumors and poorer survival. But when the researchers gave sucralose-fed mice arginine or citrulline, which is metabolized into arginine in the body, the effectiveness of immunotherapy was restored.\n\nTo assess the relevance of these findings for humans, the researchers looked at 132 patients with advanced melanoma or non-small cell lung cancer who received anti-PD1 therapy alone or in combination with chemotherapy. Patients filled out detailed diet history questionnaires that included questions about how often they consumed artificial sweeteners in coffee, tea and diet soda.\n\n\"We found that sucralose impeded the effectiveness of immunotherapies across a range of cancer types, stages and treatment modalities,\" said Davar. \"These observations raise the possibility of designing prebiotics, such as targeted nutrient supplementation for patients who consume high levels of sucralose.\"\n\nThe researchers hope to launch a clinical trial investigating whether citrulline supplements -- which boost arginine levels more than arginine itself -- affect the gut microbiome and anti-tumor immune response in patients.\n\nThey are also interested in looking at how other sugar substitutes, such as aspartame, saccharin, xylitol and stevia, impact the immune system and response to immunotherapy.\n\nOther authors on the study were Kristin Morder, M.S., Madison Nguyen, Drew Wilfahrt, Ph.D., Zakaria Dahmani, Ansen Burr, M.D., Ph.D., Bingxian Xie, Ph.D., Michael Morikone, Ph.D., Hector Nieves-Rosado, M.D., Ph.D., William Gunn, M.S., Drew Hurd, Hong Wang, Ph.D., Steven Mullett, Kaitlin Bossong, Stacy Gelhaus, Ph.D., Dhivyaa Rajasundaram, Ph.D., Lawrence Kane, Ph.D., and Greg Delgoffe, Ph.D., and Jishnu Das, Ph.D., all of Pitt or UPMC.\n\nThis research was supported by the National Institutes of Health (DP2AI177967, S10OD023402, S10OD032141, R01CA206517, R01AI138504, T32GM008208, U01 CA271407, R01 CA257265, U01 CA268806 and P50 CA254865), the Damon Runyon Cancer Research Foundation and Gateway for Cancer Research (G-22-800).",
      "url": "https://www.sciencedaily.com/releases/2025/09/250906013455.htm",
      "source": "Latest Science News -- ScienceDaily",
      "published": "2025-09-06",
      "sentiment_score": 0.85,
      "reasoning": "The article reports a significant scientific discovery showing that a common artificial sweetener, sucralose, can negatively impact cancer immunotherapy by altering gut bacteria and reducing arginine levels essential for immune cell function. Importantly, the study identifies a practical, potentially simple intervention—arginine or citrulline supplementation—that could reverse this effect and improve treatment outcomes. The research includes both human patient data and animal models, with plans for clinical trials, indicating broad relevance and real-world impact on cancer treatment strategies.",
      "category": "Health",
      "personality_title": "Common sweetener sucralose may reduce cancer immunotherapy effectiveness, but supplements could help",
      "personality_presentation": "**Context** – Sucralose is a widely used artificial sweetener found in diet sodas and other low-calorie products. Many people, including cancer patients, consume it to manage calorie intake or blood sugar levels. Immunotherapy is a cancer treatment that helps the immune system fight tumors, but its success can vary.\n\n**What happened** – Researchers at the University of Pittsburgh and UPMC Hillman Cancer Center studied how sucralose affects cancer immunotherapy. They found that patients with melanoma or lung cancer who consumed a lot of sucralose responded less well to immunotherapy and had lower survival rates. In experiments with mice, sucralose changed gut bacteria to reduce arginine, an amino acid needed by immune cells. When mice were given arginine or citrulline supplements, the immunotherapy worked better again.\n\n**Impact** – This study reveals a hidden problem with sucralose for cancer patients receiving immunotherapy. It shows how the sweetener can harm treatment by changing gut bacteria and lowering important nutrients for immune cells. Importantly, the research suggests a simple way to fix this problem by giving supplements that restore arginine levels. This could help improve cancer treatment without forcing patients to change their diets drastically.\n\n**What's next step** – The research team plans to start clinical trials to test if citrulline supplements can improve immunotherapy results in patients who consume sucralose. They also want to study how other sugar substitutes like aspartame and stevia affect the immune system during cancer treatment.\n\n**One-sentence takeaway** – Sucralose may weaken cancer immunotherapy by lowering key nutrients, but arginine or citrulline supplements could reverse this effect and improve treatment outcomes.\n",
      "personality_title_fr": "La sucralose, édulcorant courant, pourrait réduire l'efficacité de l'immunothérapie contre le cancer, mais des suppléments pourraient aider",
      "personality_presentation_fr": "**Contexte** – La sucralose est un édulcorant artificiel très utilisé, présent dans les sodas light et autres produits faibles en calories. Beaucoup de personnes, y compris des patients atteints de cancer, en consomment pour contrôler leur apport en calories ou leur taux de sucre dans le sang. L’immunothérapie est un traitement du cancer qui aide le système immunitaire à combattre les tumeurs, mais son efficacité peut varier.\n\n**Ce qui s’est passé** – Des chercheurs de l’Université de Pittsburgh et du centre UPMC Hillman ont étudié l’effet de la sucralose sur l’immunothérapie contre le cancer. Ils ont découvert que les patients atteints de mélanome ou de cancer du poumon qui consommaient beaucoup de sucralose répondaient moins bien au traitement et avaient un taux de survie plus faible. Chez la souris, la sucralose modifiait les bactéries intestinales, réduisant l’arginine, un acide aminé essentiel aux cellules immunitaires. Lorsque les souris recevaient des suppléments d’arginine ou de citrulline, l’efficacité de l’immunothérapie revenait.\n\n**Impact** – Cette étude révèle un problème caché de la sucralose pour les patients sous immunothérapie. Elle montre que l’édulcorant peut nuire au traitement en modifiant le microbiote intestinal et en diminuant des nutriments essentiels aux cellules immunitaires. Surtout, la recherche propose une solution simple : des suppléments pour restaurer l’arginine. Cela pourrait améliorer le traitement sans obliger les patients à changer radicalement leur alimentation.\n\n**Prochaine étape** – L’équipe prévoit des essais cliniques pour tester si des suppléments de citrulline améliorent les résultats de l’immunothérapie chez les patients consommant de la sucralose. Ils souhaitent aussi étudier l’impact d’autres édulcorants comme l’aspartame ou la stévia sur le système immunitaire pendant le traitement du cancer.\n\n**Phrase clé** – La sucralose peut affaiblir l’immunothérapie contre le cancer en réduisant des nutriments clés, mais des suppléments d’arginine ou de citrulline pourraient inverser cet effet et améliorer les résultats.\n",
      "personality_title_es": "El edulcorante común sucralosa puede reducir la eficacia de la inmunoterapia contra el cáncer, pero los suplementos podrían ayudar",
      "personality_presentation_es": "**Contexto** – La sucralosa es un edulcorante artificial muy usado que se encuentra en refrescos dietéticos y otros productos bajos en calorías. Muchas personas, incluidos pacientes con cáncer, la consumen para controlar las calorías o el nivel de azúcar en sangre. La inmunoterapia es un tratamiento contra el cáncer que ayuda al sistema inmunitario a combatir tumores, pero su éxito puede variar.\n\n**Qué pasó** – Investigadores de la Universidad de Pittsburgh y el Centro Oncológico UPMC Hillman estudiaron cómo afecta la sucralosa a la inmunoterapia contra el cáncer. Descubrieron que los pacientes con melanoma o cáncer de pulmón que consumían mucha sucralosa respondían peor al tratamiento y tenían menos probabilidades de sobrevivir. En experimentos con ratones, la sucralosa cambió las bacterias del intestino y redujo los niveles de arginina, un aminoácido necesario para las células inmunitarias. Cuando los ratones recibieron suplementos de arginina o citrulina, la inmunoterapia volvió a funcionar mejor.\n\n**Impacto** – Este estudio muestra un problema oculto de la sucralosa para pacientes con cáncer que reciben inmunoterapia. Demuestra cómo el edulcorante puede dañar el tratamiento al cambiar las bacterias intestinales y disminuir nutrientes importantes para las células inmunitarias. Lo más importante es que sugiere una forma sencilla de solucionar este problema con suplementos que restauran los niveles de arginina. Esto podría mejorar el tratamiento sin obligar a los pacientes a cambiar mucho su dieta.\n\n**Próximo paso** – El equipo de investigación planea iniciar ensayos clínicos para probar si los suplementos de citrulina mejoran los resultados de la inmunoterapia en pacientes que consumen sucralosa. También quieren estudiar cómo otros edulcorantes como el aspartamo y la stevia afectan el sistema inmunitario durante el tratamiento del cáncer.\n\n**Frase clave** – La sucralosa puede debilitar la inmunoterapia contra el cáncer al reducir nutrientes clave, pero los suplementos de arginina o citrulina podrían revertir este efecto y mejorar los resultados.\n",
      "image_url": "public/images/news_image_A-common-supplement-could-reverse-the-hidden-harm-.png",
      "image_prompt": "A warm, detailed painting of a healthy gut depicted as a vibrant garden where glowing, stylized amino acid molecules shaped like keys unlock bright, shield-like T cells that stand guard around shrinking, shadowy tumor shapes, while subtle swirling streams of sweetener droplets gently fade away in the background."
    },
    {
      "title": "First CRISPR horses spark controversy: what’s next for gene-edited animals?",
      "summary": "Nature, Published online: 05 September 2025; doi:10.1038/d41586-025-02800-7Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining acceptance in agriculture.",
      "content": "Scientists have bred the world’s first horses with CRISPR-mediated genomic edits to enhance their muscle power and speed.Credit: Agustin Marcarian/Reuters\n\nThese horses might look like ordinary horses, but there is something highly unusual about their genomes. They are the first of their species to have their DNA edited using CRISPR–Cas9, a technique that cuts the genome at a specific location to change gene expression and achieve a desired trait.\n\nThe horses are clones of the prize-winning steed Polo Pureza, but they have a tweak to myostatin — a gene involved in regulating muscle development — that is designed to quicken their pace. CRISPR was used in fetal fibroblasts (connective tissue cells) to generate embryos through cloning, and then the embryos were implanted into mares.\n\nThe development of these five CRISPR-edited horses ten months ago, by the non-profit research organization Kheiron Biotech in Buenos Aires, Argentina, is proving controversial among horse breeders in Argentina, where polo is extremely popular, Reuters reported on 30 August.\n\nCritics are concerned that the technology threatens people’s livelihoods and that it will compromise the tradition of using selective breeding to generate elite horses. The Argentine Polo Association has now banned the use of gene-edited horses in the sport, following the lead of similar organizations such as the International Federation for Equestrian Sports1, which banned the practice in 2019.\n\nSome scientists, however, welcome the CRISPR horses. “It’s cool to show that CRISPR works and you can create CRISPR-altered horses,” says Molly McCue, a veterinary clinician scientist at the University of Minnesota in Minneapolis. “Horse[riders] often feel very strongly about breeding as an art and not a science, but really it is both together,” she adds.\n\nThe CRISPR horses join a menagerie of gene-edited animals that have wide-ranging applications — mostly with the goal of improving agriculture. Such efforts have now transformed from a research promise to a commercial reality, says Tad Sonstegard, chief scientific officer at Acceligen, a company in Eagan, Minnesota that specializes in the precision breeding of livestock. Biological engineering ethicist Jeantine Lunshof, at Harvard Medical School in Boston, Massachusetts, puts the rise of the technology in animals down to improvements in CRISPR techniques and “a broader acceptance of gene editing”.\n\nCRISPR in agriculture\n\nAcceligen is one of a handful of companies that are using CRISPR to alter the genomes of livestock, with the goal of making animal products such as meat and milk in a more efficient manner. Its ‘PRLR-SLICK’ cattle have an edit in the prolactin receptor gene that gives them shorter, slicker hair, providing tolerance to heat stress. Sonstegard says that the short-haired PRLR-SLICK cows should be able to adapt to hotter climates and to tolerate the rising temperatures associated with climate change, increasing the accessibility of meat and dairy products to people around the world. In 2022, the US Food and Drug Administration (FDA) approved the PRLR-SLICK cattle for meat production and human consumption, deeming them a low risk to safety, but it’s unclear when the meat will hit the US market.\n\nWith a similar goal, researchers in India announced the first CRISPR-edited sheep earlier this year. As with the Argentine horses, the scientists edited the myostatin gene of the sheep to increase muscle mass — but in this case, the goal was to increase meat production rather than to speed the sheep up.\n\nScientists have used CRISPR to make pigs more resistant to porcine reproductive and respiratory syndrome, and to make their meat hypoallergenic.Credit: Acceligen\n\nDisease resistance is another reason that scientists are producing CRISPR animals. Genus, a company based in Basingstoke, UK, has used CRISPR to generate pigs that contain a mutation in the CD163 gene. This makes them resistant to a virus that causes porcine reproductive and respiratory syndrome (PRRS), which can be deadly for suckling pigs. In 2020, the FDA approved the gene-edited pigs for sale in the United States, and they are expected to go on the market there in 2026.\n\nResearchers are also using CRISPR to make animal products that are safer for human consumption. GalSafe pigs, made by Revivicor in Blacksburg, Virginia, are designed to be a source of hypoallergenic meat. Researchers use CRISPR to inactivate the GGTA1 gene, which produces alpha-gal, a sugar molecule found in most mammals that can cause allergic reactions in humans who eat red meat. Revivicor is also investigating whether organs from the pigs could be transplanted into people: the company says that the same gene edits might reduce the risk of pig organs being rejected from human bodies. The FDA approved GalSafe pigs for use in biomedical therapeutics and for human consumption in 2020.",
      "url": "https://www.nature.com/articles/d41586-025-02800-7",
      "source": "Nature",
      "published": "2025-09-07",
      "sentiment_score": 0.85,
      "reasoning": "The article reports on the successful development and application of CRISPR gene-editing technology in animals, including horses, cattle, sheep, and pigs, with significant real-world benefits such as improved agricultural efficiency, disease resistance, climate adaptation, and safer food products. These advances have broad societal impact by potentially increasing food security, reducing allergic reactions, and enabling biomedical innovations like organ transplantation. The article provides detailed context and examples, demonstrating a meaningful breakthrough in biotechnology with wide-ranging positive implications.",
      "category": "Health",
      "personality_title": "Gene-edited animals show promise in farming and medicine despite polo ban",
      "personality_presentation": "**Context** – Scientists have started using a gene-editing tool called CRISPR to change the DNA of animals. CRISPR lets them make precise changes to genes that control traits like muscle strength or disease resistance. This technology is new for animals like horses, cows, sheep, and pigs.\n\n**What happened** – In Argentina, researchers created the first horses with CRISPR changes to a gene called myostatin, which helps control muscle growth. These horses are clones of a champion polo horse but are designed to be faster. However, polo groups have banned these gene-edited horses from competitions. Meanwhile, in the United States and other countries, gene-edited cattle, sheep, and pigs have been developed to handle heat better, resist diseases, or produce safer meat. Some of these animals have been approved by authorities like the US Food and Drug Administration (FDA) for food and medical uses.\n\n**Impact** – These gene-edited animals can help farmers produce more food that is safer and better suited to changing climates. For example, cattle with short hair can stay cooler in hotter weather, and pigs resistant to certain diseases can reduce losses. Meat from specially edited pigs can cause fewer allergic reactions. These examples show how gene editing is moving from science experiments to real-world tools that can improve agriculture and health.\n\n**What's next step** – Gene-edited animals will likely become more common in farming and medicine as more products pass safety checks and reach the market. Scientists will keep improving the technology to make animals healthier and food production more efficient. At the same time, discussions about rules and ethics will continue, especially in sports and traditional breeding communities.\n\n**One-sentence takeaway** – Gene editing with CRISPR is creating animals that could help farmers grow food more efficiently and safely, even as some sports groups reject their use.\n",
      "personality_title_fr": "Des animaux génétiquement modifiés prometteurs pour l’agriculture et la médecine malgré l’interdiction au polo",
      "personality_presentation_fr": "**Contexte** – Les scientifiques utilisent un outil appelé CRISPR pour modifier l’ADN des animaux. CRISPR permet de changer précisément des gènes qui contrôlent des caractéristiques comme la force musculaire ou la résistance aux maladies. Cette technologie est nouvelle pour des animaux comme les chevaux, les vaches, les moutons et les cochons.\n\n**Ce qui s’est passé** – En Argentine, des chercheurs ont créé les premiers chevaux modifiés avec CRISPR sur un gène nommé myostatine, qui contrôle la croissance musculaire. Ces chevaux sont des clones d’un cheval de polo champion, mais conçus pour être plus rapides. Cependant, les clubs de polo ont interdit ces chevaux dans les compétitions. Pendant ce temps, aux États-Unis et ailleurs, des bovins, moutons et cochons génétiquement modifiés ont été développés pour mieux supporter la chaleur, résister aux maladies ou produire une viande plus sûre. Certains de ces animaux ont été approuvés par des autorités comme la Food and Drug Administration (FDA) américaine pour la consommation et les usages médicaux.\n\n**Impact** – Ces animaux génétiquement modifiés peuvent aider les agriculteurs à produire plus de nourriture, plus sûre et mieux adaptée aux changements climatiques. Par exemple, les bovins à poils courts restent plus frais en temps chaud, et les cochons résistants à certaines maladies réduisent les pertes. La viande de cochons modifiés peut provoquer moins d’allergies. Ces exemples montrent que la modification génétique passe de l’expérimentation à des outils concrets pour améliorer l’agriculture et la santé.\n\n**Prochaine étape** – Les animaux modifiés vont probablement devenir plus courants dans l’agriculture et la médecine, à mesure que plus de produits seront validés et commercialisés. Les scientifiques continueront d’améliorer cette technologie pour rendre les animaux plus sains et la production alimentaire plus efficace. En même temps, les débats sur les règles et l’éthique se poursuivront, notamment dans les sports et les communautés d’éleveurs traditionnels.\n\n**En une phrase** – La modification génétique par CRISPR crée des animaux qui pourraient aider les agriculteurs à produire de la nourriture plus efficacement et en toute sécurité, même si certains sports refusent leur usage.\n",
      "personality_title_es": "Animales editados genéticamente muestran beneficios en agricultura y medicina pese a prohibición en polo",
      "personality_presentation_es": "**Contexto** – Los científicos están usando una herramienta llamada CRISPR para cambiar el ADN de los animales. CRISPR permite hacer cambios precisos en genes que controlan rasgos como la fuerza muscular o la resistencia a enfermedades. Esta tecnología es nueva para animales como caballos, vacas, ovejas y cerdos.\n\n**Qué pasó** – En Argentina, investigadores crearon los primeros caballos con cambios en un gen llamado miostatina, que controla el crecimiento muscular. Estos caballos son clones de un caballo campeón de polo, pero diseñados para correr más rápido. Sin embargo, los grupos de polo prohibieron estos caballos en las competencias. Al mismo tiempo, en Estados Unidos y otros países, se han desarrollado vacas, ovejas y cerdos editados genéticamente para soportar mejor el calor, resistir enfermedades o producir carne más segura. Algunos de estos animales han sido aprobados por autoridades como la Administración de Medicamentos y Alimentos (FDA) de EE.UU. para uso alimentario y médico.\n\n**Impacto** – Estos animales editados genéticamente pueden ayudar a los agricultores a producir más alimentos que sean más seguros y adecuados para climas cambiantes. Por ejemplo, vacas con pelo corto se mantienen más frescas en clima caliente, y cerdos resistentes a ciertas enfermedades reducen pérdidas. La carne de cerdos modificados puede causar menos alergias. Estos ejemplos muestran cómo la edición genética está pasando de experimentos científicos a herramientas reales que mejoran la agricultura y la salud.\n\n**Próximo paso** – Los animales editados probablemente serán más comunes en la agricultura y la medicina a medida que más productos pasen revisiones de seguridad y lleguen al mercado. Los científicos seguirán mejorando la tecnología para hacer animales más saludables y la producción de alimentos más eficiente. Al mismo tiempo, continuarán las discusiones sobre reglas y ética, especialmente en deportes y comunidades tradicionales de cría.\n\n**Resumen en una frase** – La edición genética con CRISPR está creando animales que podrían ayudar a producir alimentos de manera más eficiente y segura, aunque algunos deportes rechacen su uso.\n",
      "image_url": "public/images/news_image_First-CRISPR-horses-spark-controversy-whats-next-f.png",
      "image_prompt": "A detailed, warm-toned painting of a majestic horse with subtly glowing muscle patterns symbolizing enhanced strength and speed, standing beside a stylized DNA double helix gently intertwined with a polo mallet, set against a soft, natural background evoking tradition and innovation harmoniously blending."
    }
  ]
}